tirzepatide no longer working A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% weight loss ✓ Semaglutide: 13.7% weight loss But weight loss isn't the Why Am I Not Losing

WADA and Athletic Use: A Blanket Ban with No Exceptions The World Anti-Doping Agency lists IGF-1 LR3 under Section S2.2 of the Prohibited ListPeptide Hormones, Growth Factors, Related Substances, and Mimeticsbanned at all times, in and out of competition

If you are experiencing unexpected period changes whilst taking Ozempic, it is important to discuss these with your GP to rule out other causes and ensure appropriate monitoring

Both firms invested over USD 11 billion combined between 2024 and 2026 to expand peptide facilities, erecting capacity barriers that delay biosimilar competition

Blue Zones under scrutiny: statistical outliers, data reliability concerns, genetics, and separating longevity correlation from causation [48:15]

Skin, connective tissue, immune signaling, oxidative stress, mitochondria, gene expression

J.CowanK